New serological markers for liver damage

Serological markers of enterocyte damage and apoptosis 1 SEROLOGICAL MARKERS OF ENTEROCYTE DAMAGE AND APOPTOSIS IN PATIENTS WITH CELIAC DISEASE, AUTOIMMUNE DIABETES MELLITUS AND DIABETES MELLITUS

New serological markers in pediatric patients with inflammatory bowel disease.

The spectrum of serological markers associated with inflammatory bowel disease (IBD) is rapidly growing. Due to frequently delayed or missed diagnoses, the application of non-invasive diagnostic tests for IBD, as well as differentiation between ulcerative colitis (UC) and Crohn's disease (CD), would be useful in the pediatric population. In addition, the combination of pancreatic autoantibodies...

A NEW DAMAGE INDEX FOR STRUCTURAL DAMAGE IDENTIFICATION BY MEANS OF WAVELET RESIDUAL FORCE

In  this  paper  a  new  method  is  presented  for  structural  damage  identification.  First,  the damaged structure is  excited by short  duration impact acceleration  and then, the  recorded structural displacement time history responses under free vibration conditions are analyzed by Continuous Wavelet Transform (CWT) and Wavelet Residual Force (WRF) is calculated. Finally, an effective d...

A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.

Cirrhosis is the end result of chronic liver damage, associated with altered serum biomarkers and lipid profile. However, only few studies regarding serum biomarkers and plasma lipid profile in non-alcoholic liver cirrhosis subjects have been undertaken in Pakistan. This study aimed to evaluate the degree of alterations of tumor markers and lipid profile in liver cirrhosis patients and in norma...

Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey.

In a study of 195 patients derived from five centres in northern Britain and with histologically confirmed alcoholic liver disease we have found an increased prevalence of serological markers of hepatitis B. This increased prevalence was found in each of the five centres; the overall frequency ranged from 11% sero-positivity in fatty liver, 12% in alcoholic hepatitis and 27% in cirrhosis.